,53 Furthermore, many of the described mutations that characterize esophageal cancer, such as TP53 and CDKN2A, also occur in precursor lesions such as Barrett’s esophagus and high-grade dysplasia, lowering the specificity of ctDNA testing.54 This evidence concerns the gene CDKN2A and esophageal adenocarcinoma.